著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
Michael A. Nauck and Daniel R. Quast,Cardiovascular Safety and Benefits of Semaglutide in Patients With Type 2 Diabetes: Findings From SUSTAIN 6 and PIONEER 6,Frontiers in Endocrinology,1664-2392,Frontiers Media SA,2021-03-29,12,,645566,https://cir.nii.ac.jp/crid/1360579819734178432,https://doi.org/10.3389/fendo.2021.645566